6533b860fe1ef96bd12c38c7
RESEARCH PRODUCT
Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579–1589
Thomas KubiakJennifer GrammesLutz HeinemannEva Kuestnersubject
Advanced and Specialized NursingInsulin pumpmedicine.medical_specialtyType 1 diabetesContinuous glucose monitoringbusiness.industryEndocrinology Diabetes and MetabolismInsulinmedicine.medical_treatmentMEDLINE030209 endocrinology & metabolismmedicine.disease03 medical and health sciences0302 clinical medicineDiabetes mellitusBlood Glucose Self-MonitoringEmergency medicineHealth careInternal Medicinemedicine030212 general & internal medicinebusinessdescription
We applaud Umpierrez and Klonoff (1) for reviewing the evidence on the application of insulin pump therapy (continuous subcutaneous glucose infusion [CSII]) and continuous glucose monitoring in inpatient settings. However, we missed a dedicated section about the patients’ perspective and experiences concerning insulin pump use in hospitals. In a qualitative survey conducted in Germany, elderly patients with type 1 diabetes (≥65 years, n = 136) and health care professionals (HCP, n = 96) were asked about their wishes, concerns, and needs related to CSII (2). The 290 responses (165 patients; 125 HCPs) were classified into three categories. First were positive experiences (patients n = 17; HCPs n = 5), which were a result of perceived respect of the …
year | journal | country | edition | language |
---|---|---|---|---|
2019-03-11 | Diabetes Care |